Pyelonephritis represents urinary tract infection (UTI) that affects the upper urinary tract. Because it may affect the kidneys, it is a more serious UTI
Women are at higher risk of developing UTI than men. Below, there is a danger that women's UTI will increase.
Women are more likely to be infected during the menstrual cycle or at certain times during pregnancy
In men, UTI is usually the result of sexually transmitted diseases, or it may develop when there is a problem with the flow of urine.
Yellow granulomatous pyelonephritis is a rare chronic pyelonephritis. It causes severe kidney damage and leads to the formation of granulomatous abscess. Patients infected with yellow granulomatous pyelonephritis experience recurrence, anemia, kidney stones and functional loss of the affected kidney. Urine cultures and antibiotic susceptibility tests were performed on patients considered to be suffering from pyelonephritis. Because most cases of pyelonephritis are caused by bacterial infections, antibiotics are a common treatment option. Depending on the type of infectious organism and the antibiotic susceptibility characteristics of the organism, the treatment may include fluoroquinolone, cephalosporin, aminoglycoside or trimethoprim, alone or in combination. Treatment of patients with yellow granulomatous pyelonephritis may include antibiotics and surgery
In people suspected of pyelonephritis, urine culture and antibiotic susceptibility tests are performed, so treatment can be finally adjusted to the infected organism. Because most cases of pyelonephritis are caused by bacterial infections, antibiotics are the main basis of treatment. The choice of antibiotic depends on the type of organism and the susceptibility of the antibiotic and may include fluoroquinolone, cephalosporin, aminoglycoside or trimethoprim / sulfamethoxazole, alone or in combination.
Simple pyelonephritis is not a fatal disease of the antibiotic era. When a secondary condition develops, pyelonephritis includes emphysematous pyelonephritis (20 to 80% mortality rate), perirenal abscess (20 to 50% mortality rate), or one of sepsis syndrome (>) 25% of the total mortality rate) In emphysematous pyelonephritis, regardless of treatment, the mortality rate in the case of gas localization in renal parenchyma is 60%. If the gas spreads around the kidneys and the patient is being treated with antibiotics only, the mortality rate is 80%. For emphysematous nephritis, the mortality rate is 20%.